Stan Hashimoto

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse, A. Verier, M. Valis, 2018, Multiple sclerosis and related disorders.

IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.

J. Selhorst, C. Kollman, R. Kinkel, 2006, Neurology.